Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Pathology Department, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Blood Cancer J. 2024 Sep 23;14(1):166. doi: 10.1038/s41408-024-01146-z.
Mantle cell lymphoma (MCL) is genetically characterized by the IG::CCND1 translocation mediated by an aberrant V(D)J rearrangement. CCND1 translocations and overexpression have been identified in occasional aggressive B-cell lymphomas with unusual features for MCL. The mechanism generating CCND1 rearrangements in these tumors and their genomic profile are not known. We have reconstructed the IG::CCND1 translocations and the genomic profile of 13 SOX11-negative aggressive B-cell lymphomas using whole genome/exome and target sequencing. The mechanism behind the translocation was an aberrant V(D)J rearrangement in three tumors and by an anomalous IGH class-switch recombination (CSR) or somatic hypermutation (SHM) mechanism in ten. The tumors with a V(D)J-mediated translocation were two blastoid MCL and one high-grade B-cell lymphoma. None of them had a mutational profile suggestive of DLBCL. The ten tumors with CSR/SHM-mediated IGH::CCND1 were mainly large B-cell lymphomas, with mutated genes commonly seen in DLBCL and BCL6 rearrangements in 6. Two cases, which transformed from marginal zone lymphomas, carried mutations in KLF2, TNFAIP3 and KMT2D. These findings expand the spectrum of tumors carrying CCND1 rearrangement that may occur as a secondary event in DLBCL mediated by aberrant CSR/SHM and associated with a mutational profile different from that of MCL.
套细胞淋巴瘤(MCL)的遗传学特征是由异常的 V(D)J 重排介导的 IG::CCND1 易位。在具有 MCL 罕见特征的偶发性侵袭性 B 细胞淋巴瘤中,已鉴定出 CCND1 易位和过表达。这些肿瘤中产生 CCND1 重排的机制及其基因组特征尚不清楚。我们使用全基因组/外显子和靶向测序重建了 13 例 SOX11 阴性侵袭性 B 细胞淋巴瘤的 IG::CCND1 易位和基因组图谱。易位背后的机制在三个肿瘤中是异常的 V(D)J 重排,在十个肿瘤中是异常的 IGH 类别转换重组(CSR)或体细胞超突变(SHM)机制。由 V(D)J 介导易位的肿瘤是两个 blastoid MCL 和一个高级别 B 细胞淋巴瘤。它们都没有提示 DLBCL 的突变特征。由 CSR/SHM 介导的 IGH::CCND1 的十个肿瘤主要是大 B 细胞淋巴瘤,通常具有 DLBCL 中常见的突变基因和 6 例 BCL6 重排。两个从边缘区淋巴瘤转化而来的病例携带 KLF2、TNFAIP3 和 KMT2D 的突变。这些发现扩展了携带 CCND1 重排的肿瘤谱,这些肿瘤可能作为异常 CSR/SHM 介导的 DLBCL 的继发事件发生,并与 MCL 的突变特征不同。